8YY
vs
F
FTSE Straits Times Singapore
8YY
Over the past 12 months, 8YY has significantly outperformed FTSE Straits Times Singapore, delivering a return of +37% compared to the FTSE Straits Times Singapore's 0% growth.
Stocks Performance
8YY vs FTSE Straits Times Singapore
Performance Gap
8YY vs FTSE Straits Times Singapore
Performance By Year
8YY vs FTSE Straits Times Singapore
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Biolidics Ltd
Glance View
Biolidics Ltd. operates as a medical technology company. The firm is primarily engaged in the research, experimental development, marketing, and distribution of biotechnology, life and medical science and electronics-related industrial design services and investment holdings. The company segments include cancer, infectious diseases and laboratory services. The cancer segment involves the identifying and assessing collaboration partners, technology, products and services, product development, and the management of global distributorship networks and direct customers in the cancer field. The infectious diseases segment involves the identifying and assessing collaboration partners, technology, products and services, product development, and the management of global distributorship networks and direct customers in the infectious diseases field. The laboratory services segment involves the business, operation and provision of laboratory services to customers.